These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8813140)

  • 1. Excision of 2',2'-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA.
    Gandhi V; Legha J; Chen F; Hertel LW; Plunkett W
    Cancer Res; 1996 Oct; 56(19):4453-9. PubMed ID: 8813140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
    Huang P; Chubb S; Hertel LW; Grindey GB; Plunkett W
    Cancer Res; 1991 Nov; 51(22):6110-7. PubMed ID: 1718594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase.
    Fowler JD; Brown JA; Johnson KA; Suo Z
    J Biol Chem; 2008 May; 283(22):15339-48. PubMed ID: 18378680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragment.
    Schy WE; Hertel LW; Kroin JS; Bloom LB; Goodman MF; Richardson FC
    Cancer Res; 1993 Oct; 53(19):4582-7. PubMed ID: 8402631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical characteristics of gemcitabine.
    Plunkett W; Huang P; Gandhi V
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():7-13. PubMed ID: 8718419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the 3' --> 5' exonuclease of human DNA polymerase epsilon by fludarabine-terminated DNA.
    Kamiya K; Huang P; Plunkett W
    J Biol Chem; 1996 Aug; 271(32):19428-35. PubMed ID: 8702631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):393-400. PubMed ID: 10065109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.
    Prakasha Gowda AS; Polizzi JM; Eckert KA; Spratt TE
    Biochemistry; 2010 Jun; 49(23):4833-40. PubMed ID: 20459144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Mechanism of Gemcitabine and Its Phosphates: DNA Polymerization Disruption via 3'-5' Exonuclease Inhibition.
    Yang S; Luo D; Li N; Li C; Tang S; Huang Z
    Biochemistry; 2020 Nov; 59(45):4344-4352. PubMed ID: 33147009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
    Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymerase mutagenic bypass and proofreading of endogenous DNA lesions.
    Eckert KA; Opresko PL
    Mutat Res; 1999 Mar; 424(1-2):221-36. PubMed ID: 10064863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of DNA templates containing 5-formyluracil, a major oxidative lesion of thymine in DNA.
    Zhang QM; Sugiyama H; Miyabe I; Matsuda S; Saito I; Yonei S
    Nucleic Acids Res; 1997 Oct; 25(20):3969-73. PubMed ID: 9321644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
    Plunkett W; Huang P; Xu YZ; Heinemann V; Grunewald R; Gandhi V
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):3-10. PubMed ID: 7481842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine: preclinical pharmacology and mechanisms of action.
    Plunkett W; Huang P; Searcy CE; Gandhi V
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):3-15. PubMed ID: 8893876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-off regulation of 3' exonuclease excision to DNA polymerization by Exo+ polymerase.
    Zhang J; Li K
    J Biochem Mol Biol; 2003 Nov; 36(6):525-8. PubMed ID: 14659068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation.
    Heinemann V; Xu YZ; Chubb S; Sen A; Hertel LW; Grindey GB; Plunkett W
    Cancer Res; 1992 Feb; 52(3):533-9. PubMed ID: 1732039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells.
    Gandhi V; Mineishi S; Huang P; Chapman AJ; Yang Y; Chen F; Nowak B; Chubb S; Hertel LW; Plunkett W
    Cancer Res; 1995 Apr; 55(7):1517-24. PubMed ID: 7533664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new motif required for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I (Klenow fragment): the RRRY motif is necessary for the binding of single-stranded DNA substrate and the template strand of the mismatched duplex.
    Kukreti P; Singh K; Ketkar A; Modak MJ
    J Biol Chem; 2008 Jun; 283(26):17979-90. PubMed ID: 18448432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine.
    Grunewald R; Abbruzzese JL; Tarassoff P; Plunkett W
    Cancer Chemother Pharmacol; 1991; 27(4):258-62. PubMed ID: 1998982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay.
    Su KY; Lai HM; Goodman SD; Hu WY; Cheng WC; Lin LI; Yang YC; Fang WH
    DNA Repair (Amst); 2018 Jan; 61():63-75. PubMed ID: 29223016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.